Earnings Just Put Dan Loeb's Bets To The Test — Here's What Held Up
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 13 2025
0mins
Should l Buy CNK?
Source: Benzinga
Earnings Insights: Dan Loeb's Third Point portfolio revealed mixed earnings results across various sectors, with Cinemark reducing its stake and reporting losses, while Corpay's sales missed estimates despite an EPS in line with consensus. Jacobs Solutions exceeded revenue expectations, while Primo Brands showed significant revenue growth but fell short of analyst estimates.
Stock Performance: Year-to-date performance varied among the companies, with Cinemark down 2.13%, Corpay up 3.32%, Jacobs down 4.57%, and Primo Brands increasing by 3.35%, reflecting differing market responses to their earnings reports and forecasts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CNK?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CNK
Wall Street analysts forecast CNK stock price to rise
6 Analyst Rating
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 28.150
Low
28.00
Averages
33.67
High
37.00
Current: 28.150
Low
28.00
Averages
33.67
High
37.00
About CNK
Cinemark Holdings, Inc. is a movie theatre company. The Company is engaged in the motion picture exhibition industry, with theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. Its circuit, comprised of various brands that also include Century, Tinseltown and Rave, operates approximately 497 theaters with 5,653 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as concert, sporting and gaming events, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Box Office Recovery: Year-to-date, domestic box office receipts have reached $1.56 billion, reflecting a 20% increase from last year, indicating a strong resurgence of audience interest in theaters and the potential for industry recovery.
- Cinemark's Strong Performance: Cinemark has maintained profitability for three consecutive years, with a modest 15% increase in outstanding shares compared to AMC's 34%, positioning it favorably in the market and likely to attract more investor attention.
- IMAX's Business Advantage: IMAX generated $410 million in revenue last year and has seen a decline in share count post-COVID, leveraging its unique viewing experience and upcoming blockbuster releases to drive future revenue growth.
- EPR Properties Investment Opportunity: EPR Properties, focusing on experiential properties, currently offers a dividend yield exceeding 7%, and its diversified investment strategy is poised to provide stable cash flow as the theater industry continues to recover.
See More
- Significant Box Office Growth: Year-to-date, domestic movie ticket sales have reached $1.56 billion, representing a 20% increase compared to last year, indicating a strong trend of audience return to theaters post-pandemic and suggesting potential for industry recovery.
- Competitor Performance Comparison: Cinemark and Imax have remained profitable over the past three years, with Cinemark's share count increasing only 15%, while AMC's has surged by 34%, highlighting AMC's poor performance in shareholder returns, which may affect its future financing capabilities.
- IMAX Business Advantage: IMAX generated $410 million in revenue last year, marking an all-time high, and attracts audiences with its unique viewing experience, particularly for superhero and action films, with a promising slate of releases in the coming years.
- EPR Properties Investment Opportunity: EPR Properties, a REIT focused on experiential properties, currently offers a yield above 7% and recently increased its dividend, suggesting that if the movie industry continues to recover, it will provide investors with stable cash flow and growth potential.
See More
- Quant Ratings Overview: As the earnings season concludes, investors are focusing on updated quant ratings for mid-cap communication services companies, revealing varied fundamental performances among firms with market caps between $2B and $10B.
- Top-Rated Companies: Sphere Entertainment (SPHR) receives a quant rating of 4.95, classified as a 'Strong Buy', indicating robust performance in profitability and growth, thereby attracting investor interest.
- Lowest-Rated Companies: Grindr (GRND) has a quant rating of 1.49, marked as a 'Strong Sell', reflecting weak fundamentals that may raise investor concerns about its future performance.
- Market Trends: Overall, quant ratings provide investors with a snapshot of company valuation, growth, and profitability, aiding in identifying potential outperformers or laggards for future investment decisions.
See More
- Massive Merger Potential: The merger between Paramount and Warner Bros. has an enterprise value of $111 billion and aims to produce 30 films annually, with 15 from each studio, potentially resulting in a powerful slate of 26 films in 2027, significantly enhancing market competitiveness.
- Optimistic Box Office Outlook: Warner Bros.' high-budget films like 'The Batman' and 'Minecraft Movie' have performed exceptionally well at the global box office, with the former earning $772 million and the latter nearing $1 billion, laying a solid foundation for the combined box office performance and potentially making it the largest single studio in 2027.
- Intensified Market Competition: The merged entity will face fierce competition from Disney and Universal, which are also set to release strong franchises, and while the merger presents potential box office advantages, uncertainties remain, particularly regarding audience overlap.
- Distribution Strategy Challenges: The combined company plans to release 30 films over 52 weekends, necessitating precise distribution strategies to avoid cannibalizing ticket sales, especially with Paramount's 'Sonic the Hedgehog 4' scheduled just a week before Warner's 'Godzilla X Kong: Supernova', which may require adjustments to optimize revenue.
See More
- Full Exit: Marathon Asset Management disclosed in an SEC filing that it fully liquidated its Cinemark Holdings position in Q4 2025, amounting to approximately $8.41 million, reflecting a cautious approach towards market volatility that may influence future investment strategies.
- Change in Holdings: Cinemark previously represented 11.2% of Marathon's AUM, and with this exit, the firm's asset allocation will become more concentrated in other investments, potentially reducing the diversification of its portfolio risk.
- Financial Performance: Cinemark generated over $3.1 billion in revenue in 2025, with a net income of $136.6 million; however, its stock price has dropped 22.4% over the past year, indicating market concerns about its future growth and potentially impacting investor confidence.
- Market Environment Challenges: Cinemark's business model heavily relies on consumer behavior and content cycles, and while it is stabilizing post-pandemic, the stock's volatility reflects the competitive pressures and uncertainties facing the theatrical industry.
See More
- Film Overview: The new documentary 'The Story of Everything' is set to release in theaters nationwide from April 30 to May 6, 2026, aiming to challenge traditional views on the origin of the universe and the existence of God by presenting new evidence from cosmology, physics, and molecular biology that encourages audiences to rethink humanity's origins and purpose.
- Production Team Background: Produced by the team behind 'When Calls the Heart' and 'After Death', with executive producer Lee Strobel, a bestselling author, and scientific exploration led by Dr. Stephen C. Meyer, a Cambridge-trained philosopher of science, ensuring the film's scientific credibility and depth.
- Scientific Evidence Presentation: The film emphasizes that significant scientific discoveries do not point away from God but rather directly toward His existence, based on research into the fine-tuning of physical laws and the information encoded in DNA, aiming to provoke deep reflection on the relationship between science and faith among viewers.
- Ticket Information: Tickets for 'The Story of Everything' will be available on March 13, 2026, through Fathom Entertainment and participating theaters, providing audiences not only a challenge to scientific beliefs but also an opportunity to re-examine the origins of the universe and life itself.
See More










